Nonmuscle invasive bladder cancer: a primer on immunotherapy. - Wikidata - wikimedia - TriplyDB

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

http://www.wikidata.org/entity/Q37094072

about

New therapies in nonmuscle invasive bladder cancer treatment.

P2860

Q49519778-11B2E298-1E93-480A-996F-0FBE9FA84EDD

P2860

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

http://www.wikidata.org/entity/Q37094072

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

@en

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

@nl

type

label

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

@en

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

@nl

prefLabel

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

@en

Nonmuscle invasive bladder cancer: a primer on immunotherapy.

@nl

P1433

Q37094072-63896E14-0452-4793-AFD0-4A36AE8B0F0A

P1476

Q37094072-8AF9C107-8787-4692-A268-1AA00F18FED8

P2093

Q37094072-7E6A6AE4-0799-49EA-8B03-4BB3E009E2DA

Q37094072-A7AD5183-9E8A-4E83-862F-DA0C23476975

P2860

Q37094072-0414D51B-065E-4F1D-8D1B-4F706755C3CC

Q37094072-0868EAFE-EED2-4111-8548-46277521FA4F

Q37094072-08E6F771-DC77-4673-B7FD-D862DB703C7C

Q37094072-0E2E8BB9-585B-4DC4-9C51-7CD241555A34

Q37094072-1070A700-BD1D-442E-B082-A66741D00E39

Q37094072-160F1B50-0363-43FC-80A7-0C9BFF1D3008

Q37094072-1A51B03D-67C7-408B-A268-E6BF4683BBD7

Q37094072-1D2EEFE5-C73F-42FF-86D3-267765A9ACA5

Q37094072-319A83A9-ED31-43DD-969C-D9A46BDB4167

Q37094072-346466FC-ACA9-4791-A0AE-196F312877DC

P304

Q37094072-B796BADC-E350-44B6-8809-9577306B84FB

P31

Q37094072-E4B0EA87-2230-4A5F-BDCE-72F0E450DB93

P356

Q37094072-035E4FF0-42C7-40AD-B116-AB30A17D22FF

P433

Q37094072-F65C861A-8842-48DA-88BB-81BDDCBA3F8D

P478

Q37094072-FFBB49E9-475A-47B4-A52B-2FB92C07EF21

P50

Q37094072-3057E8FD-CA01-4AEF-823B-7BFD6E2FC8F6

P577

Q37094072-C3174758-5CC2-4E04-B1CB-00A1149219DD

P698

Q37094072-F2BC195B-0F9B-4E2D-A493-1069C303EBEA

P921

Q37094072-DDC88889-C62E-43B3-B5D5-DD1741669F0D

P932

Q37094072-24E737CB-A004-447D-86A3-A03A03CBA2A7

P356

J.ISSN.2095-3941.2016.0020

P1433

Cancer biology & medicine

P1476

Nonmuscle invasive bladder cancer: a primer on immunotherapy

@en

P2093

Mahir Maruf

http://www.w3.org/2001/XMLSchema#string

Piyush K Agarwal

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer

Cancer immunology - development of novel anti-cancer therapies

Cancer statistics, 2015

PD-1 and its ligands in tolerance and immunity

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

Chimeric antigen receptor T cells for sustained remissions in leukemia

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

P304

194-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.20892/J.ISSN.2095-3941.2016.0020

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27458527

http://www.w3.org/2001/XMLSchema#string

P921

P932

4944546

http://www.w3.org/2001/XMLSchema#string